NORTHERN TRUST CORP - CYCLACEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$5,000
-44.4%
13,3990.0%0.00%
Q4 2019$9,000
+80.0%
13,3990.0%0.00%
Q3 2019$5,000
-28.6%
13,3990.0%0.00%
Q2 2019$7,000
-46.2%
13,3990.0%0.00%
Q1 2019$13,000
+62.5%
13,3990.0%0.00%
Q4 2018$8,000
-55.6%
13,3990.0%0.00%
Q3 2018$18,000
-5.3%
13,3990.0%0.00%
Q2 2018$19,000
+5.6%
13,3990.0%0.00%
Q1 2018$18,00013,3990.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 559,900$2,111,0000.75%
WEDBUSH SECURITIES INC 13,900$52,0000.01%
MinichMacGregor Wealth Management, LLC 800$3,0000.00%
UBS Group AG 180$1,0000.00%
D'Orazio & Associates, Inc. 100$00.00%
DIMENSIONAL FUND ADVISORS LP 30,913$117,0000.00%
Parallel Advisors, LLC 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 21,692$82,0000.00%
DEUTSCHE BANK AG\ 2,403$9,0000.00%
PANAGORA ASSET MANAGEMENT INC 10,346$39,0000.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders